Old Web
English
Sign In
Acemap
>
authorDetail
>
Sergei I. Petrykiv
Sergei I. Petrykiv
University Medical Center Groningen
Medicine
Internal medicine
Endocrinology
Albuminuria
Dapagliflozin
9
Papers
315
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Author response for "Exposure‐response relationships of the sodium‐glucose co‐transporter 2 inhibitor dapagliflozin for renal risk markers"
2020
Diabetes, Obesity and Metabolism
Marjolein Y. A. M. Kroonen
Jeroen V. Koomen
Sergei I. Petrykiv
Gozewijn D. Laverman
Hiddo J.L. Heerspink
Jasper Stevens
Show All
Source
Cite
Save
Citations (0)
Exposure‐response relationships of the sodium‐glucose co‐transporter 2 inhibitor dapagliflozin for renal risk markers
2020
Diabetes, Obesity and Metabolism
Marjolein Y. A. M. Kroonen
Jeroen V. Koomen
Sergei I. Petrykiv
Gozewijn D. Laverman
Hiddo J.L. Heerspink
Jasper Stevens
Show All
Source
Cite
Save
Citations (1)
Effects of Dapagliflozin on Circulating Markers of Phosphate Homeostasis
2019
Clinical Journal of The American Society of Nephrology
Maarten A. de Jong
Sergei I. Petrykiv
Gozewijn D. Laverman
Antonius E. van Herwaarden
Dick de Zeeuw
Stephan J. L. Bakker
Hiddo J. Lambers-Heerspink
Martin H. de Borst
Show All
Source
Cite
Save
Citations (30)
Does SGLT2 inhibition with dapagliflozin overcome individual therapy resistance to RAAS inhibition
2018
Diabetes, Obesity and Metabolism
Sergei I. Petrykiv
Gozewijn D. Laverman
Dick de Zeeuw
Hiddo J. Lambers-Heerspink
Show All
Source
Cite
Save
Citations (11)
Pooled Analysis of Multiple Crossover Trials To Optimize Individual Therapy Response to Renin-Angiotensin-Aldosterone System Intervention
2017
Clinical Journal of The American Society of Nephrology
Sergei I. Petrykiv
Gozewijn D. Laverman
Frederik Persson
Liffert Vogt
Peter Rossing
Martin H. de Borst
Ron T. Gansevoort
Dick de Zeeuw
Hiddo J. Lambers-Heerspink
Show All
Source
Cite
Save
Citations (6)
1